SEC Tracker
Get the app

Traws Pharma TRAW

Traws Pharma to hold virtual meeting for stock split approval

Preliminary proxy statement

Form
PRE 14A
Filed
Importance
Routine
  1. Special meeting scheduled for [ ], 2026
  2. Proposal to approve reverse stock split at 1-for-8 to 1-for-15 ratio
  3. Board recommends voting for both proposals
  4. Virtual format with no physical location

Written from the PRE 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Traws Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Mannatech MTEX public float $10M, Jun 30, 2025
  2. LeonaBio ATHA public float $10M, Jun 30, 2025
  3. BioCardia BCDA public float $10M, Jun 30, 2025
  4. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
  5. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025